Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
14
pubmed:dateCreated
1999-8-2
pubmed:abstractText
alpha-Synuclein has been implicated in the pathophysiology of many neurodegenerative diseases, including Parkinson's disease (PD) and Alzheimer's disease. Mutations in alpha-synuclein cause some cases of familial PD (Polymeropoulos et al., 1997; Kruger et al., 1998). In addition, many neurodegenerative diseases show accumulation of alpha-synuclein in dystrophic neurites and in Lewy bodies (Spillantini et al., 1998). Here, we show that alpha-synuclein shares physical and functional homology with 14-3-3 proteins, which are a family of ubiquitous cytoplasmic chaperones. Regions of alpha-synuclein and 14-3-3 proteins share over 40% homology. In addition, alpha-synuclein binds to 14-3-3 proteins, as well as some proteins known to associate with 14-3-3, including protein kinase C, BAD, and extracellular regulated kinase, but not Raf-1. We also show that overexpression of alpha-synuclein inhibits protein kinase C activity. The association of alpha-synuclein with BAD and inhibition of protein kinase C suggests that increased expression of alpha-synuclein could be harmful. Consistent with this hypothesis, we observed that overexpression of wild-type alpha-synuclein is toxic, and overexpression of alpha-synuclein containing the A53T or A30P mutations exhibits even greater toxicity. The activity and binding profile of alpha-synuclein suggests that it might act as a protein chaperone and that accumulation of alpha-synuclein could contribute to cell death in neurodegenerative diseases.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1529-2401
pubmed:author
pubmed:issnType
Electronic
pubmed:day
15
pubmed:volume
19
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5782-91
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:10407019-14-3-3 Proteins, pubmed-meshheading:10407019-Amino Acid Sequence, pubmed-meshheading:10407019-Amino Acid Substitution, pubmed-meshheading:10407019-Binding Sites, pubmed-meshheading:10407019-Cell Line, pubmed-meshheading:10407019-Cloning, Molecular, pubmed-meshheading:10407019-Enzyme Inhibitors, pubmed-meshheading:10407019-Gene Expression Regulation, pubmed-meshheading:10407019-Humans, pubmed-meshheading:10407019-Molecular Sequence Data, pubmed-meshheading:10407019-Nerve Tissue Proteins, pubmed-meshheading:10407019-Phosphoproteins, pubmed-meshheading:10407019-Point Mutation, pubmed-meshheading:10407019-Protein Kinase C, pubmed-meshheading:10407019-Proteins, pubmed-meshheading:10407019-Recombinant Proteins, pubmed-meshheading:10407019-Sequence Alignment, pubmed-meshheading:10407019-Sequence Homology, Amino Acid, pubmed-meshheading:10407019-Synucleins, pubmed-meshheading:10407019-Transfection, pubmed-meshheading:10407019-Tyrosine 3-Monooxygenase, pubmed-meshheading:10407019-alpha-Synuclein
pubmed:year
1999
pubmed:articleTitle
alpha-Synuclein shares physical and functional homology with 14-3-3 proteins.
pubmed:affiliation
Department of Pharmacology, Loyola University Medical Center, Maywood, Illinois 60153, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't